Roles of mTOR in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and the number of patients affected is increasing worldwide. Thus, there is a need to establish a new treatment for DKD to improve the renal prognosis of diabetic patients. Recently, it has shown that intracellular metabol...
Saved in:
Main Authors: | Mako Yasuda-Yamahara (Author), Shinji Kume (Author), Hiroshi Maegawa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of mTOR in age-related diseases
by: Zofia Chrienova, et al.
Published: (2021) -
mTOR in Human Diseases
by: Dormond, Olivier
Published: (2019) -
mTOR Signaling in Metabolism and Cancer
Published: (2020) -
Unraveling DDIT4 in the VDR-mTOR pathway: a novel target for drug discovery in diabetic kidney disease
by: Hai-tao Lu, et al.
Published: (2024) -
Place of mTOR inhibitors in management of BKV infection after kidney transplantation
by: Thomas Jouve, et al.
Published: (2016)